1542-1543 / 2953
Cost effectiveness
• More expensive initial cost
• Gynaecological patients:
• Increasingly cost effective with time
• Lower toxicity
• Post operative pts
• Too expensive unless treating PA nodes
Chen et al Gynecol Oncol 2015;136:521. Lesnock et al Gynecol Oncol 2013;129: 574